---
title: Min Jun
---

网站: <https://www.junsurgical.com/contact>

电话: {{< telephone "+1 415-625-3230" >}}

电子邮件: <CAReception@CraneCTS.com>

Min Jun 在纽约大学医学院从 Dr. Rachel Bluebond-Langner 学习了机器人辅助阴道成形术的技术。他提供 SRS 及 SRS 修复的手术服务。Min Jun 现时 <sub>2022 年 2 月</sub>的手术地点位于 San Francis Memorial Hospital．

## 特点

Min Jun 所使用的技术为 Da Vinci 机器人辅助的腹膜阴道成形术。该技术从下腹开出 4-6 个 2cm 左右的刀口，并将机器人放进去，从腹部开始游离腹膜。他使用阴囊皮肤作为外部阴道皮肤以及阴唇皮肤；阴茎皮肤及龟头作为阴蒂附近的皮肤和阴蒂。这样的好处是因为阴蒂周围的皮肤得以保留，阴蒂的完整性和美观性可以得到增强。机器人接下来从内部缝合腹膜和皮肤的衔接部位，并完成手术。

## 要求

- Crane Center 要求至少有两封精神科医生的信和一封 HRT 医生的信（推荐信内容的具体要求在页面底部）
- 必须在拿到推荐信之后才能开始预约手术
- BMI 要求：强制要求低于 35，但是在正常范围内为最佳（因为伤口缝合原因）
- 年龄要求：18 岁及以上无需家长同意，16 岁到 17 岁需要家长同意

## 流程

1. 在官网 Contact 处预约 Initial Consultation 并预留保险信息（必须写清保险信息才能约上）
1. 签署 Initial Consultation 的知情同意书
1. 参加 Initial Consultation，可以向 Min Jun 提问
1. 拿到信之后发邮件预约手术
1. 获得手术日期，可以选择加入 Cancellation list（如果前面有人取消有机会提前手术时间）
1. 在临近手术日期时处理好保险问题，并在术前一个月内完成所需要的血液检查（会提前通过邮件发过来所有所需的东西）
1. 手术两日前在 Crane Center 进行术前咨询
1. 术后大约 2-3 天后出院，在 SF 附近休养
1. 术后 7，14，21 天在 Crane Center 进行术后检查
1. 术后 7 天后拆包，并开始通模具。一开始通模具的频率为一天 4 次，每次 15 分钟。之后会随时间减少次数。

## 保险

现时（2022 年 2 月），Crane Center 旧金山接受的网络内保险有：

- Cigna PPO
- Blue Cross/Blue Shield PPO
- Western Health Advantage
- Shutter Select
- San Francisco Health Plan/Healthy SF
- EHN/WebTPA (Whole Foods)

其他 PPO 保险需要提前和 Crane Center 进行沟通。

现时无法接受的保险有：

- Medicare
- Medicaid
- State Medi-Cal/Straight Medi-Cal/Fee-for-Service Medi-Cal
- Tri-Care
- Kaiser

## 术后照片（NSFW）

[（英文 Reddit 链接）](https://www.reddit.com/r/Transgender_Surgeries/search/?q=min%20jun&restrict_sr=1&sr_nsfw=)

## 推荐信要求（英文）

**Two Letters from 2 different licensed mental health specialists**

- 1 letter can be from a provider who has only had an evaluative role
- At least one of the letters must be from a provider with a doctorate level degree (Ph.D., Psy.D., etc.)
- Texas patients: Blue Cross Blue Shield of Texas requires two letters from a Doctorate level provider (Ph.D., Psy.D. or Psychiatrist)
- The mental health provider letter(s) must include ALL of the following:
  - Patient’s legal and preferred name
  - Patient’s date of birth
  - Date provider/patient relationship began and the frequency of contact
  - A statement that the patient has been diagnosed with persistent, well-documented gender dysphoria/gender identity disorder and exhibits all of the following:
  - The desire to live and be accepted as a member of the opposite sex, usually accompanied by the wish to make his or her body as congruent as possible with the preferred sex through surgery and hormone treatment; and
  - The transgender identity has been present persistently for at least two years; and
  - The disorder is not a symptom of another mental health disorder; and
  - The disorder causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
  - Documentation that the patient has completed a minimum of 12 continuous months of living in a gender role that is congruent with their gender identity, across a wide range of life experience and events that may occur throughout the year.
  - The patient has undergone a minimum of 12 continuous months of hormone therapy (recommended for bottom surgery and breast augmentation only).
  - A statement that the patient has the capacity to make fully informed decisions and to consent for treatment.
  - That the patient is able to comply with long term follow-up requirements and post- operative expectations have been addressed.
  - If the patient has significant medical or mental health issues present, they must be reasonably well controlled.
  - Any substance use (marijuana, alcohol, etc.) is well controlled for at least 6 months prior to the patient’s surgical date.
  - The provider must state their experience with treating patients diagnosed with gender dysphoria.
- The letter from your Hormone Provider must include:
  - Patient’s legal and preferred name
  - Patient’s date of birth
  - Date provider/patient relationship began and the frequency of contact
  - Date hormone therapy began and the frequency of treatment
  - That the patient has undergone a minimum of 12 continuous months of hormone replacement therapy
  - If the patient has a contraindication to hormone therapy, please note this
